DONLIZ
MRP: 990
Packaging: 10X10
Pack Type: tablet
Composition:
Donepezil Hcl. 5mg & Memantine Hcl 10mg
Indication:
For the Treatment of Moderate to Severe Dementia of the Alzheimers Type
Description:
Donepezil HCl 5mg and Memantine HCl 10mg combination is a clinically approved medication for the management of moderate to severe Alzheimer’s disease and other neurodegenerative dementias. Donepezil is an acetylcholinesterase inhibitor, which enhances cholinergic function, while Memantine is an NMDA receptor antagonist, helping protect neurons from excitotoxic damage.
This dual-therapy works synergistically to improve cognition, memory, attention, and daily functioning, providing better outcomes compared to monotherapy.
Tags:
- Enhances memory, cognition, and focus
- Delays worsening of dementia symptoms
- Improves daily activity performance
- Reduces confusion, aggression, and irritability
- Once-daily dosing improves adherence
Usage Information
Dosage
Standard Dose: One tablet daily (Donepezil 5mg + Memantine 10mg) Take with or after food Swallow whole with water; do not crush or chew Use consistently at the same time every day Note: Dose may be adjusted by a physician based on patient response.
Side Effects
Common: Headache Nausea or vomiting Drowsiness or dizziness Loss of appetite Diarrhea or constipation Rare/Serious: Bradycardia (slow heart rate) Hallucinations Confusion Fainting Muscle cramps
Contraindications
Known hypersensitivity to Donepezil or Memantine Severe liver or kidney impairment Uncontrolled cardiac conditions Active peptic ulcers or GI bleeding
Availability
Donepezil Memantine tablet, Alzheimer’s medication, cognitive decline treatment, memory enhancer medicine, dementia care, dual-action brain support